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In, mukivariateanalyses, FFS patientswere more likelyto undergoan-
giography(Odds ratio= 1.3 ci 1.1–1.6), butthere was no differencein the
use of revascularization.We concludethat the processof care is aimilarin
FFS and managedesre patientswithUAP,althoughFFS patientsare more
likely to undergo angiography.
m1010141 TheEconomicConaequencesofsNewTherspyDependontheTypeof ReimbursementPlen
W.S. Weintraub,C. Warner,P.D. Mauldin,E. Becker,D. Gomea,J. Cook,
A. Kosinski,S. Boccuzzi,forthe RESTORE EconomicStudyGroup.Emory
University Atlanta, GA, USA
New therapieshave complexeconomic consaquencea. Consider the case
of an effective therapy to prevant restenosis after PTCA. Assume the initial
provider Coatis $12,000& restenosis (R) causes 20% repeat PTCAS,yield-
ing $2400 followup costs, or $14,400 total. Assume therapy decreasing R
50% costs $1000. Initial cost becomes $13,000 & followup $1300, a $100
savings total. Assume fee for service (FFS) providare charga cost +10%.
This describes a model of cost of R, varying in impact on provider & payer
depending on the type of reimbursement. (table, signs:+ cost, - savings).
Providers Pavers
Initial 6 Months initial 6 Months
Fee for Servica -$100 +$90 +$1100 -$1200
Packsgs Prica +$600 +$200 o -$1200
Capifsted +$1100 –$900 o 0
ReatenoaisPrevented
0.0 0.2 0.4 O.e 0.8 1.0
Under FFS, the payer takes the rick and provider consequences are
minimal. The aituation is reversed with cavitation.WithpackagePricin9, the
provider loses duetocost of therapy & Ieaaprocedures while the payer gains.
Sensitivity analyeis was used to further explore the model (see figure); in this
example under FFS, as therapy improved from no restenosis preventad
to 100% prevented, the payer savingsincreaaadfrom Oto $2400. A new
therapy may have considerable economic consequences, varying with time
& provider vs payer perspective.
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m1011 1 IncompleteReetorstionof LuminalDimensionAfterPTCAin RestenosticStentedSegments:An
IntravascularUltrasoundAnalysis
G. G5rge, T. Konotza,E. Voagele,J. Ge, M. Haude, F. Liu,R. Erbal.Dep. of
Cardiology, University Hospital Essen, FRG, Germany
The mechanisms of PTCA in reetenosed etentad segments is incompletely
understood. Therefore, 24 patients with a > 50% diameter stenosis at six-
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month follow up (F-UP) were studied by intravascular ultrasound (IVUS,
30 MHz mechanical cathetera) and quantitative angiogrephy (QCA) after the
initial PTCA1,after stent implantation (Palmaz-Schatz, PS), at FU-P,and after
PTCA2 in reetenoeadstents. Thirty-one PS atents were implanted with IVUS
guidancein24 coronarylesions.Balloondiameterduringstent implantation
was 3.34 + 0.4 mm, and pressure 16 + 2 atm. Acute Iuminal area gain due
to stenting after PTCA was 4 mm2.At F-UP,minimal Iuminal diameter (QCA)
wae 1,3 * 0.5 mm. Stent area was unchanged (7.6 + 2 mm2 vs. 8 + 2.1
mmz at F.up). PTCAZ in the restenotic segments was performed with 11.1
+ 4.4 atm. Balloon size was unchanged compared with stent deployment.
Vessel area after PTCA2 increased from 19 & 5 mti to 21 + 7 mm2 and
stant area from 8 + 2.1 mm2to 9 + 2.5 mm2 (NS). The final lumen area was
significantly smaller compared to the acute procedure.
Conclusion: Intimal hyperplasia is the main cause for atent restenosis in
PS stents. PTCA2 resulted in only minor vessel and PS remodeling without
achieving the initial lumen diameters. This finding underlines the potential
role of debulking devices for treatment of in-stent restenosis.
11011-2I OPtimalCoronarYBalloonAngioPlastyvsStent
(OCBAS):PreliminaryResulteof a Randomized
Trial
A. Rodriguez, F.Ayala, C. Pardiilas, O. Santaera, M. Fernandez,
V. Bemardi, C. Mauvecin, I.F. Palacios. Anchorena and OtamemfiHoapifa/s,
Buenos Aires, Argentina, Massachusetts General Hospitsl, Boston, MA,
USA
Coronary stenting reducaa reetenoais in lesions with early deterioration (>
0.3 mm) in minimal Iuminal diameter (MLD) occurring within the fimt 24,hs
after suceeesfulPTCA (early loss). Lesions with no early loss after eucceseful
PTCA have a low restenoaia rate. This study was deaignad to compare im-
mediate results and restenosis rate of lesions treated with coronary stenting
vs. those treatad with optimal PTCA (good immediate result and no early
loss at 30 minutes post-PTCA angiography). From December of 1995 to July
of 1996116 patients were randomized to stent (n = 57) or PTCA (n = 59).
Primary success was achieved in all patients in the PTCA and in the stent
groups; 13.5% of the PTCA group patients cross over to stent due to sub-
optimal results or early lose. Immediate quantitative coronary angiographic
results follow:
PTCA Stent D
Reference Diameter 2.S k 0.6 2.9 + 0.6 na
MLD post-lntewention 2,2* 0,4 2.8 * 0.6 <0,001
MLD 30 minpost-PTCA 2.2 + 0,5 -
Acute Gain 1.4 1.9 < .02
Stenoaiapeat (%) 17* 10 11 k 10 <0,01
Conclusion.’1)Coronary stenting achieves greater acute gain than opti-
mal PTCA. 2) Angiographic restenosis data will be available at the time of
presentation.
1o11-3 TheAbsenceof D Alleleofthe ACEIDGenotype
PreventsRestenoeisAfterCoronaryStenting:A
QuantitativeAngiographicStudy
A. Dellavalle, G. Steffenino, F. Ribichini, G. Matullo 1, E. Colajanni
A. Vado, E. Uslenghi, A. Piazzal. Osp. S. Croce, Cuneo, Italy t Ist. di
Genetica, Univ di Torino, /tafy
The angiotensin converting enzyme (ACE) l/D polymorphism is of uncertain
aignifieartce in reetenosie after PTCA (R). From Dee. ’93 to Dec. ’95, 115
patients (p) (101 men, age61 + 9 y) were treatad with a first, elective, aingle-
veaael eoronaty Palmaz-Schafz stenting (CS) (130 etente in 115 lesions,
deployed at 14-20 atm with a balloon-vessel ratio = 1). P with ID diabetes,
aorto-ostial lesions, total occlusion >2 w&eks, leaion longer than 30 mm
DID (3S p) l/D (49 p) 1/1(26 p) p vslue (*)
D-ref (mm)
Ssfore PTCA 2.97 d 0.41 2,94 + 0,51 3.10 * 0.50 NS
After CS 3.15 * 0.36 3.14 * 0.39 3.29 + 0.67 NS
Follow-uP 2.94 + 0.44 2,S5 + 0,51 2,97 + 0.64 NS
MLD (mm)
Before PTCA 0.72 k 0.44 0.6S + 0.42 0.s3 * 0.54 FE
After CS 2.72 + 0.3S 2.67 & 0.35 2,85 + 0,65 NS
FOIIW-UP 1.s4 i 0.s2 1.ss * 0.s4 2,32 + 0,51 <0.05
“6DS
Safore PTCA 74* 14 74* 14 72& 13 NS
Aflar CS 15 i 7.7 15* S.1 13 h 6.S NS
Follow-uP 3S & 25 32+ 1S 26& 10 <0.05
% DS ? 50”A 12/36 (31”A) 6/49 (12%) 0/26 <0.C4XM
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were excluded.ACE inhibitorswere not administeredin the six months
follow-upperiod.Thepolimerasechainreactionmethodwasusedtoanalyze
the l/D polymorphism.Twop had subacuteocclusion(1.7%)and 113had
angiogrephy(A) at 6.2 + 1.7 months.Quantitativecoronaryanalysiswas
performedintwoorthogonalviewsbeforeandafterPTCAandat sixmonths
follow-up(f-up)(table).(*)Analysisof thevarfance.
Noaignificsntdifferencewasfoundat f-up A amongp withthe D allele,
whilethe VIgenotypeseemato preventlateIuminalnarrowingafterCS.
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E.Alt,J. Paaquantonio,C. Beilharz,D.Preter,T.Fliedner,W.Erhardl,
A. Stembergerl,A. Schbmig.1/. Med.Klinik,Inst.forExp.Surgerx
TschnischeUniversitdtMtincherr,GermarrxKlinikumrechtsderlsq
TwhniacheUnivemittJtMOnchen,Germany,DeufschesHerzzentmm,
TwhniecheUniveKSiti5tM(h?chan,Garmany
Background:Restenosisremainsa”majorconcerflincoronaryarterystefltiflg.
Thepurposeof thisstudywaatoexaminetheeffectof thesymmetryofstent
strutsandvascularinjuryon restenosis.
Methods:Thirty-twoPalmez-Schatzslottedtubestentswereimplantedin
16healthysheepinboththeIAD andLCX.After30dayshistomorphometric
analysiswaspdormed withstentstrutsintact.Neointimalthickness,injury
index,andstentsymmetryweremeasuredin segmentsfor eachindividual
strut.Symmetrywasquantifiedby angularburden,a measurementof the
segmentof openvesselwall supportedby eachstrut relatedto the total
circumference,expressedin degrees.
Results:Histomorphometricresultswereasfollows(mean+ SD):neoin-
timalthickness=360+ 160wm;injuryindex= 0.4+ 0.6;angularburden=
24.2+ Il.@. Therewassignificantpositivecorrelationbetweenneointima
thicknessandangularburden(p < 0.02)andbetwwn neointimathickness
andinjury(p < 0.01).
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Conclusion:Stentsymmetryandvascularinjurybothhavestrongeffects
on experimentalrestenosis.This finding impliesthat stentewhichexpand
moreasymmetricallyand distributeforce evenlyalongthe vesselwall will
experienwIesalatelumenarea10ss.
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R.Komateu,M.Ueda,M.Kawasaki,N.Monta,Y.Naketeuchi,K.Fujii,
M.Nakeo,S.Toyama,A.E.Becker.OsakaCifyUniversityMedicSISchOOl,
Osaka,Japan,AcademicMedicalCentecAmsterdam,TheNetherlands
Coronarystentingpresentlyiswidelyacceptedasa methodto preventearly
occlusionafter percutaneoustransluminalcoronaryangioplaety(PTCA)or
directionalcoronaryatherectomy(DCA).However,complicationsdo occur,
suchseacuteor subacutethrombosis,and“late”restenosiscertainlyis not
completelyabolished.Thusfar, little ia knownwith regardto the pathology
after stentingin humancoronaryarteries.We investigatedimmunocyto-
chemicsllythe cellularcompositionof the neointimaaftercoronarystenting
in humans.Six coronaryarteries,obtainedfrom 6 patientswho had died
6 daysto 12 monthsafter stenting,werestudied.Onlyone patientdevel-
opedclinicalrestenosis.Monoclinalantibodiesagainstsmoothmusclecells
(SMCS),macrophages(M 0) and endotheliaicells were used.At 6 days
afterstenting(n = 1), thrombiwith accumulationof someM @wereseen
aroundthe wiresof the stent.At 1 month(n = 1),eartyneointimalprolifera-
tioncomposedof actin-negativespindlecells,actin-positiveSMCSand M@
wasfound,intermingledwith remnantsof thrombus.Threearterieswithout
restenoeis(5-12 monthsafter stenting)showeda diatinctneointimapre-
dominantlycomposedof SMCS.Thearterywith restenosis(5 monthsafter
stenting)revealedalmosttotalocclusiondueto a richlyvascularizedneointi-
malproliferation,whichcontainedSMCSandabundantMO.Thesefindings
showthatcoronarystentingin humansis associatedwithneointimalforma-
tion. The strikingneovascularizationin the casewith restenosissuggests
thatongoingorganizationof stent-relatedthrombosismayplaya role.
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M.E.Kleinman,G.D.Cipolla,J. Cui,N.Chronos,S.B.KingIll,
K.A.Robinson.Dapt.of Medicine(Cardiology)EmoryUniversitySchoolof
Medicine,Atlanta,GA,USA
Stentseliminateacuteand chronicrecoilafter PTCAbut are associated
withgreaterneointimaformation,whichmaybedueto stimulationof cellular
proliferation(CP).We testedwhetherstentscausedgreaterarterialwall
CP than balloonangioplasty(AP)by giving3H-thymidine(100 ~Ci/kg IV)
to rabbitsat 3, 7, 14,and 28 d afterAP in one iliacarteryand stent in the
contralateralartety,asameasureoftheextentofDNAsynthesia.Thearleries
wereexcised2 hafterinjectionofthenucleicacidradiolabel,solubilized,and
radioactivitywasmeasuredby liquidscintillationcounting.
Rasu/ts:Peaksampleradioactivitywasobservedat3d for bothstentand
AP,and decreasedthereafter.At 14d (2.52+ 0.47 vs 1.064C0.42 nCi,p
< 0.05)and 26 d (2.21+ 0.95 vs 0.53 + 0.14 nCi, p = 0.056),however,
radioactivitywashigherin stentthanin AP.
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Conclusions.’Stentimplantationcausedincreasedlate (2 and4 wk)cel-
lular proliferationcomparedto ballcenangioplasfyin the iliac arteriesof
normalrabbits.Greaterneointimaformationobsenmdfor stentedhuman
arteriesmaybeexplainedin partbycontinuedlatecellularproliferation.
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H.Yokoi,H.Nosaka,T.Kimure,T.Tamura,Y.Nakagawa,N. Hamaaakl,
M.Nobuyoehi.KokursMemorfa/Hospital,Kitakyushu,Japan
Recentreportsshowedthat betterlate outcomeof coronarystentingwas
primarilyrelatedto the minimallumendiameter(MLD)immediatelyafterthe
procedure,andthe useof high-pressurestentdilatation(HPSD)achieved
the biggerMLDby IVUSexaminations.The purposeof.the presentstudy
was to investigatethe impactof HPSDon late angiographicand cllnical
outcomewithPalmsz-Schatz(PS)stentimplantation.Asof December1994,
mnsecutive192patients(pts)(212lesions)underwentsuccessfulsinglePS
stentimplantationfor new,discrete(< 15mm)lesionsin larger(> 3.0 mm)
coronaryarteries,excludingvein graft,total ecclusionand severecalcified
lesions.Accordingto final balloonpressure,these pts were divided into
threegroups:lowpressure(< 10atm),mediumpressure(lC-14 atm),high
pressure(> 14atm).Follow-up(FU)quantitativeangiographywasobtained
fmm1971esions(93%)after6monthsorearlierwhenindicatedbysymptoms.
